-
3 Biotech Companies Insiders Keep Buying
Thursday, March 17, 2016 - 8:20am | 651Read More...Insiders continue to snap up seeming bargains, even with the markets on the rise. Three biotech companies saw notable insider purchases recently. Strong insider buying is often considered a positive sign for investors, particularly during volatile periods. While the markets may be up from their...
-
Oppenheimer: We Still Love OvaScience
Wednesday, April 8, 2015 - 8:51am | 232Read More...In a report published Wednesday, Oppenheimer analyst Rohit Vanjani discussed a recent investor meeting with OvaScience Inc (NASDAQ: OVAS)'s management team, including the company's Chief Executive Officer Dr. Michelle Dipp. OvaScience noted that both patient and physician inquiries have moved...
-
Analyst Calls OvaScience Study 'Promising,' But Shares Sink
Friday, March 27, 2015 - 12:17pm | 244Read More...OvaScience Inc (NASDAQ: OVAS) shares were off nearly 6 percent Friday following a company conference call with analysts concerning its fertility treatment. The Cambridge, Massachusetts-based company changed hands recently at $44.49, down $3.80. The shares have gained more than 180 percent in...
